Valuation : Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.41M 1.33M 1.21M 2.28M 157M 2.29M 15.72M 6.14M 79.15M 6.16M 6.03M 262M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7M 6.57M 6M 11.29M 777M 11.33M 77.92M 30.4M 392M 30.52M 29.86M 1.3B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
-0.13%-6.44%+60.47%+112.05% 1,047B
+0.85%-0.81%+52.77%+63.15% 646B
-1.03%-3.58%+22.87%+73.29% 451B
-1.46%-4.50%+37.43%+38.41% 355B
-0.72%-2.89%+21.86%+36.79% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+51.40%+68.55% 234B
+0.08%-1.78%-17.64%-54.29% 203B
-2.14%-0.30%+29.42%+89.10% 181B
Average -10.64%-2.68%+28.88%+48.82% 406.59B
Weighted average by Cap. -0.48%-3.46%+38.66%+65.51%

Financials

2007 2008
Net sales 23.47M 20.22M 18.96M 17.31M 32.6M 2.24B 32.71M 225M 87.76M 1.13B 88.1M 86.19M 3.75B 25.96M 22.37M 20.97M 19.15M 36.07M 2.48B 36.18M 249M 97.09M 1.25B 97.47M 95.34M 4.15B
Net income -20.86M -17.97M -16.85M -15.38M -28.98M -1.99B -29.07M -200M -78.01M -1.01B -78.31M -76.61M -3.34B -4.01M -3.45M -3.24M -2.95M -5.57M -383M -5.58M -38.4M -14.98M -193M -15.04M -14.71M -641M
Net Debt 18.79M 16.19M 15.18M 13.86M 26.11M 1.8B 26.19M 180M 70.27M 907M 70.55M 69.01M 3.01B 6.49M 5.59M 5.24M 4.79M 9.01M 620M 9.04M 62.19M 24.27M 313M 24.36M 23.83M 1.04B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-